Dermatology · San Diego, CA
NPI
1891012969
Since 2010
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7060 Clairemont Mesa Blvd
San Diego, CA, 92111
Phone (805) 252-0642
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,458
43 services
Medicare patients, 2024
20
Average age 71
Drug cost, 2024
$729K
1,704 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Julie B Ritchie prescribed most often to Medicare patients was Clobetasol Propionate, with 201 prescriptions and refills. In total Julie B Ritchie wrote 1,704 Medicare prescriptions that cost $729K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 201 | 207 | 96 | $5,247 |
| Fluorouracil Generic | 186 | 186 | 141 | $6,897 |
| Triamcinolone Acetonide Generic | 154 | 181 | 105 | $2,577 |
| Retin-A Tretinoin | 122 | 133 | 57 | $2,981 |
| Doxycycline Monohydrate Generic | 83 | 124 | 41 | $1,874 |
| Ketoconazole Generic | 81 | 88 | 42 | $1,197 |
| Tacrolimus Generic | 75 | 75 | 40 | $3,752 |
| Metronidazole Generic | 73 | 74 | 31 | $1,089 |
| Calcipotriene Generic | 63 | 64 | 54 | $5,763 |
| Hydrocortisone Generic | 48 | 53 | 31 | $743 |
| Ivermectin Generic | 40 | 40 | 13 | $5,642 |
| Dupixent Pen Dupilumab | 35 | 35 | Under 11 | $132K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 35 | 36 | Under 11 | $108K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 35 | 40 | 12 | $1,174 |
| Fluocinonide Generic | 34 | 44 | 24 | $805 |
Brand drugs: 332 claims; generic drugs: 1,372 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Julie B Ritchie were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.